Magenta Therapeutics Probability of Future Stock Price Finishing Under 0.38
Magenta Therapeutics' future price is the expected price of Magenta Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Magenta Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Please specify Magenta Therapeutics' target price for which you would like Magenta Therapeutics odds to be computed.
Magenta |
Magenta Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Magenta Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Magenta Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Magenta Therapeutics is not yet fully synchronised with the market data | |
| Magenta Therapeutics has some characteristics of a very speculative penny stock | |
| Magenta Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (76.46 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Magenta Therapeutics currently holds about 128.28 M in cash with (67.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.13. | |
| Roughly 63.0% of the company shares are owned by institutional investors |
Magenta Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Magenta Stock often depends not only on the future outlook of the current and potential Magenta Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Magenta Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 59.4 M | |
| Cash And Short Term Investments | 112 M |
Magenta Therapeutics Technical Analysis
Magenta Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Magenta Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Magenta Therapeutics. In general, you should focus on analyzing Magenta Stock price patterns and their correlations with different microeconomic environments and drivers.
Magenta Therapeutics Predictive Forecast Models
Magenta Therapeutics' time-series forecasting models is one of many Magenta Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Magenta Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Magenta Therapeutics
Checking the ongoing alerts about Magenta Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Magenta Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Magenta Therapeutics is not yet fully synchronised with the market data | |
| Magenta Therapeutics has some characteristics of a very speculative penny stock | |
| Magenta Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (76.46 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Magenta Therapeutics currently holds about 128.28 M in cash with (67.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.13. | |
| Roughly 63.0% of the company shares are owned by institutional investors |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Magenta Stock
If you are still planning to invest in Magenta Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Magenta Therapeutics' history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |